Testing the safety of immunotherapy in diabetes – FierceBiotech
|
Testing the safety of immunotherapy in diabetes
FierceBiotech Diabetes occurs when the T cells of the immune system destroy beta cells in the pancreas that produce insulin. Diabetes researchers have long been interested in using immunotherapy techniques to tamp down this wayward immune activity, but they've … |
